Results
71,134 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 30 | Lyons EmerChief Accounting Officer |  ICLRICON PLCOpen-market sale | SELL | $9,952 54 sh | Oct 26, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 30 | Lyons EmerChief Accounting Officer | ICLRICON PLC Open-market sale | SELL | $9,952 54 sh | Oct 26, 2026 |
| 30 | Lyons EmerChief Accounting Officer | ICLRICON PLC Open-market sale | SELL | $15K 81 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 30 | Zadoks Jeff ADirector |  POSTPost Holdings, Inc.Tax withholding | F | $1.40M 17.9K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 30 | Gray Diedre JEVP, GC & CAO, SECY | POSTPost Holdings, Inc. Tax withholding | F | $1.46M 18.7K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 29 | Linetsky DavidPresident, Network Solutions |  PHRPhreesia, Inc.Open-market purchase | BUY | $320 35 sh | Oct 26, 2026 traded Oct 22, 2026 |
| 29 | Tucker Steven B.Director |  SMBKSMARTFINANCIAL INC.Open-market sale | SELL | $173K 3,500 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 29 | Guthart Gary SDirector |  ISRGINTUITIVE SURGICAL INCOpen-market sale · 10b5-1 plan | SELL | $9.08M 20.1K sh | Oct 26, 2026 traded Oct 23, 2026 |
| 29 | Linetsky DavidPresident, Network Solutions | PHRPhreesia, Inc. Open-market purchase | BUY | $362 35 sh | Oct 26, 2026 traded Oct 22, 2026 |
| 28 | Tsang Chi KeungDirector, Chief Executive Officer |  BMNRBITMINE IMMERSION TECHNOLOGIES, INC.Option exercise | M | — 142 sh | Oct 26, 2026 traded Apr 23, 2026 |
| 28 | Opaleye Management Inc.10% Owner |  ACOGAlpha Cognition Inc.Open-market purchase | BUY | $123K 15.0K sh | Oct 26, 2026 traded Oct 23, 2026 |
| 28 | Opaleye Management Inc.10% Owner |  GRCEGrace Therapeutics, Inc.Open-market purchase | BUY | $117K 66.4K sh | Oct 26, 2026 traded Oct 26, 2026 |
| 26 | Jordan Rhett D.EVP & CHIEF CREDIT OFFICER | SMBKSMARTFINANCIAL INC. Open-market sale | SELL | $9,960 200 sh | Oct 26, 2026 traded Oct 26, 2026 |
| 26 | Lyons EmerChief Accounting Officer | ICLRICON PLC Open-market sale | SELL | $9,538 52 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 26 | Lyons EmerChief Accounting Officer | ICLRICON PLC Open-market sale | SELL | $7,583 42 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 26 | Lyons EmerChief Accounting Officer | ICLRICON PLC Open-market sale | SELL | $7,839 43 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 25 | Opaleye Management Inc.10% Owner | GRCEGrace Therapeutics, Inc. Open-market purchase | BUY | $41K 21.4K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 25 | Eagan John BuckleyGeneral Counsel |  BBTBeacon Financial CorpOpen-market sale | SELL | $20K 641 sh | Oct 26, 2026 traded Oct 26, 2026 |
| 25 | Leslie Ericka TChief Administrative Officer |  GSGOLDMAN SACHS GROUP INCOpen-market sale | SELL | $163K 183 sh | Oct 26, 2026 traded Oct 22, 2026 |
| 25 | Leslie Ericka TChief Administrative Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $60K 67 sh | Oct 26, 2026 traded Oct 22, 2026 |
| 25 | Spence John YogiVice President |  XFLTXAI Floating Rate & Alternative Income TrustOpen-market purchase | BUY | $17K 1,000 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 24 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Grant or award | A | — 15.1K sh | Oct 26, 2026 traded Apr 2, 2026 |
| 24 | Bachrodt AmyChief Financial Officer, 10% Owner |  LYCALycia Therapeutics, Inc.Grant or award | A | — 399.7K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Grant or award | A | — 4,186 sh | Oct 26, 2026 traded Apr 7, 2026 |
| 24 | Staben StevenChief Scientific Officer, 10% Owner | LYCALycia Therapeutics, Inc. Grant or award | A | — 110.9K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Reuter EmilyCHIEF FINANCIAL OFFICER |  CARTMaplebear Inc.Open-market sale · 10b5-1 plan | SELL | $2.75M 50.0K sh | Oct 26, 2026 traded Oct 23, 2026 |
| 24 | Henderson JaneDirector | LYCALycia Therapeutics, Inc. Grant or award | A | — 57.7K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Wilson Kenneth L.GEVP Chief Wealth Officer |  CFRCULLEN/FROST BANKERS, INC.Tax withholding | F | $193K 1,230 sh | Oct 26, 2026 traded Oct 24, 2026 |
| 24 | Touami SofiaChief Business Officer | LYCALycia Therapeutics, Inc. Grant or award | A | — 68.8K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Option exercise | M | — 142 sh | Oct 26, 2026 traded Jul 23, 2026 |
| 24 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Grant or award | A | — 30.2K sh | Oct 26, 2026 traded Apr 2, 2026 |
| 24 | Lee Chin HyokChief Medical Officer, 10% Owner | LYCALycia Therapeutics, Inc. Grant or award | A | — 73.2K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Trombley Aetna WunDirector, President and CEO, 10% Owner | LYCALycia Therapeutics, Inc. Grant or award | A | — 443.6K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Archer TimothyPresident and CEO |  LRCXLAM RESEARCH CORPOpen-market sale · 10b5-1 plan | SELL | $7.13M 31.4K sh | Oct 26, 2026 traded Oct 23, 2026 |
| 24 | Fischer LaurentDirector | LYCALycia Therapeutics, Inc. Grant or award | A | — 13.3K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 23 | Perriman Damien AlanChief Commercial Officer |  EXOZEXOZYMES INC.Option exercise | M | — 3,922 sh | Oct 26, 2026 traded Oct 9, 2026 |
| 23 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Tax withholding | F | $34K 1,294 sh | Oct 26, 2026 traded Sep 30, 2026 |
| 23 | Perriman Damien AlanChief Commercial Officer | EXOZEXOZYMES INC. Option exercise | M | — 3,922 sh | Oct 26, 2026 traded Oct 9, 2026 |
| 22 | Rogers CampbellChief Medical Officer |  HTFLHeartflow, Inc.Open-market sale · 10b5-1 plan | SELL | $1.32M 23.9K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 22 | Grimme ArneDirector |  NBISNebius Group N.V.Open-market purchase · 10b5-1 plan | BUY | $58K 357 sh | Oct 26, 2026 traded Oct 22, 2026 |
| 22 | Westphal Mark WPRES., FOODSERVICE | POSTPost Holdings, Inc. Tax withholding | F | $1.37M 17.5K sh | Oct 26, 2026 traded Oct 22, 2026 |